Cargando…
Quality assessment of cellular therapies: the emerging role of molecular assays
Cellular therapies are becoming increasingly important in treating cancer, hematologic malignancies, autoimmune disorders, and damaged tissue. These therapies are becoming more effective and are being used more frequently, but they are also becoming more complex. As a result, quality testing is beco...
Autores principales: | Stroncek, David F., Jin, Ping, Ren, Jiaqiang, Feng, Ji, Castiello, Luciano, Civini, Sara, Wang, Ena, Marincola, Francesco M., Sabatino, Marianna |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983004/ https://www.ncbi.nlm.nih.gov/pubmed/21120158 http://dx.doi.org/10.5045/kjh.2010.45.1.14 |
Ejemplares similares
-
Leukemia cells induce changes in human bone marrow stromal cells
por: Civini, Sara, et al.
Publicado: (2013) -
Potency analysis of cellular therapies: the emerging role of molecular assays
por: Stroncek, David F, et al.
Publicado: (2007) -
Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies
por: Jin, Ping, et al.
Publicado: (2010) -
15 kDa Granulysin versus GM-CSF for monocytes differentiation: analogies and differences at the transcriptome level
por: Castiello, Luciano, et al.
Publicado: (2011) -
Comparison of endometrial regenerative cells and bone marrow stromal cells
por: Wang, Huan, et al.
Publicado: (2012)